Deal facts
- Buyer
- company owned by Luis Collantes
- Target
- Creo Medical SL
- Deal value
- Not disclosed
- Announced
- 22 May 2026
- Status
- Possible offer
- Sector
- Healthcare
- Country
- Spain
- Consideration
- cash
Sources
A company owned by Luis Collantes has agreed to acquire a minority stake in Creo Medical SL, a healthcare business based in Spain. The transaction involves cash consideration, though the specific financial value remains undisclosed. This deal was announced on 22 May 2026 and is currently classified as a possible offer. The target operates within the healthcare sector, while the buyer's country of origin is not reported in available records.
The acquisition represents a strategic entry into the Spanish healthcare market through a minority investment rather than a full takeover. As the deal is still in the early stages, it remains subject to further developments before any final agreement is reached. The transaction is subject to regulatory approval and further due diligence before completion.
More M&A Tools
Explore the Toolkit
Tools, frameworks and AI assistants designed for entrepreneurs serious about M&A.
Access nowDeal timeline
1 update- Possible offer
Proposed Sale of 49% Interest in Creo Medical SL
Disclaimer* THIS ANNOUNCEMENT WAS DEEMED BY THE COMPANY TO CONTAIN INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATIONS (EU) NO. 596/2014 AS THEY FORM PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018. WITH THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN. Creo Medical Group plc ("Cr
LSE RNS
Explore
Browse adjacent archives
Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.
Similar deals
Similar deals
Other Healthcare M&A activity tracked by Exit Mode.
Live Oak Health LLC to acquire Adia Labs LLC
Live Oak Health LLC has agreed to acquire a minority stake in Adia Labs LLC. The transaction, which was completed on 30 September 2026, involved a total equity value of…
- Buyer
- Live Oak Health LLC
- Target
- Adia Labs LLC
- Deal value
- USD 1,500,000
- Deal type
- minority stake
Creative Medical Technology Holdings, Inc. to acquire BioDefense, Inc.
Creative Medical Technology Holdings, Inc. has agreed to acquire a minority stake in BioDefense, Inc. The transaction was announced on 25 September 2026 and completed on…
- Buyer
- Creative Medical Technology Holdings, Inc.
- Target
- BioDefense, Inc.
- Deal value
- Not disclosed
- Deal type
- minority stake
YA II PN, LTD to acquire JUPITER NEUROSCIENCES, INC.
YA II PN, LTD and JUPITER NEUROSCIENCES, INC. entered the Exit Mode archive.
- Buyer
- YA II PN, LTD
- Target
- JUPITER NEUROSCIENCES, INC.
- Deal value
- USD 1,860,000
- Deal type
- minority stake
Cronos Group Inc. to acquire CanAdelaar B.V.
Cronos Group Inc. has agreed to acquire CanAdelaar B.V. in a strategic acquisition within the healthcare sector. The Canadian buyer will purchase the Dutch target for a…
- Buyer
- Cronos Group Inc.
- Target
- CanAdelaar B.V.
- Deal value
- EUR 57,500,000
- Deal type
- strategic acquisition
Laboratory Corporation of America Holdings to acquire BioReference Health, LLC
Laboratory Corporation of America Holdings has agreed to acquire BioReference Health, LLC in a transaction valued at 722 million US dollars. The deal, announced on 14 Oc…
- Buyer
- Laboratory Corporation of America Holdings
- Target
- BioReference Health, LLC
- Deal value
- USD 722,000,000
- Deal type
- asset sale
Buyer history
company owned by Luis Collantes
See every published Exit Mode archive entry where this buyer appears.
View buyer profileMethodology
How this page is built
Layer 1 facts come from source documents, Layer 2 turns those facts into a readable narrative, and Layer 3 only appears where the editorial team flags a founder-relevant deal.
Back to the archive